Results 31 to 40 of about 590,699 (329)

Serum NFL discriminates Parkinson disease from atypical parkinsonisms [PDF]

open access: bronzeNeurology, 2019
To investigate the diagnostic value of serum neurofilament light chain (NFL) in patients with clear signs of parkinsonism but whose specific diagnosis was yet uncertain.Serum samples were collected from patients with clear signs of parkinsonism but with uncertain diagnosis at the inclusion.
Tainá M. Marques   +7 more
openalex   +4 more sources

Cutaneous nerve fiber pathology and function in Parkinson's disease and atypical parkinsonism - a cohort study. [PDF]

open access: goldNPJ Parkinsons Dis
Andréasson M   +7 more
europepmc   +3 more sources

The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System Atrophy

open access: yesDiagnostics, 2023
Progressive Supranuclear Palsy and Multiple-System Atrophy are entities within the spectrum of atypical parkinsonism. The role of imaging methods in the diagnosis and differentiation between PSP and MSA is limited and Magnetic Resonance Imaging (MRI) is ...
Michał Kutyłowski   +5 more
doaj   +1 more source

Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism. [PDF]

open access: goldEur J Neurol
Kobylecki C   +16 more
europepmc   +3 more sources

TARDBP mutations in a cohort of Italian patients with Parkinson’s disease and atypical parkinsonisms

open access: yesFrontiers in Aging Neuroscience, 2022
BackgroundAggregates of TAR DNA-binding protein of 43 kDa (TDP-43) represent the pathological hallmark of most amyotrophic lateral sclerosis (ALS) and of nearly 50% of frontotemporal dementia (FTD) cases but were also observed to occur as secondary ...
Cinzia Tiloca   +17 more
doaj   +1 more source

Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms [PDF]

open access: goldBMC Neurology, 2019
Abstract Background: Parkinson’s disease (PD) and atypical parkinsonisms (APD) have overlapping symptoms challenging an early diagnosis. Diagnostic accuracy is important because PD and APD have different prognosis and response to treatment. We aimed to identify diagnostic inflammatory biomarkers of PD and APD in cerebrospinal fluid (CSF) using ...
Anna Santaella   +6 more
openalex   +6 more sources

The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)

open access: yesDiagnostics, 2022
Multiple System Atrophy—Parkinsonism Predominant (MSA-P) and Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) are the clinical manifestations of atypical parkinsonism. Currently, there are no efficient in vivo methods available relating to
Piotr Alster   +9 more
doaj   +1 more source

Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism

open access: yesFluids and Barriers of the CNS, 2021
Vascular dementia (VaD) and atypical parkinsonism often present with symptoms that can resemble idiopathic normal pressure hydrocephalus (iNPH) and enlarged cerebral ventricles, and can be challenging differential diagnoses.
D. Fällmar   +5 more
semanticscholar   +1 more source

Neurological manifestations of glutamic acid decarboxylase autoimmunity in Indian patients

open access: yesAnnals of Indian Academy of Neurology, 2023
Objective: To study the neurological manifestations of glutamic acid decarboxylase (GAD 65) autoimmunity in Indian patients. Methods: Retrospective study conducted in a tertiary care referral hospital in South India.
Meena Thevarkalam   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy